Axplora Invests $60 Million in HPAPI Expansion at Farmabios Site in Italy
$60 million investment to expand highly potent API (HPAPI) development and manufacturing at Axplora’s Farmabios site in Gropello Cairoli, Italy.
Farmabios
Axplora Announces €35 Million Expansion at Farmabios
Axplora to expand its Farmabios site in Gropello Cairoli, Italy, with a €35 million investment.
Axplora’s Farmabios Gets cGMP Approval for New Production Unit in Italy
Farmabios, a company of the Axplora group founded in 2022, has received the cGMP approval from AIFA (national public body regulating medicines for human use in Italy) for the first line of its new production unit at Gropello Cairoli, Italy, expanding its large scale manufacturing capabilities for high potent active pharmaceutical ingredients (HPAPIs) and steroids.
Axplora Aims to Make Pharmaceutical Supply Chains More Stable
Interview with Sylke Hassel, previous CEO of PharmaZell and current CEO of Axplora following the merger with Novasep.
